Full View

Transcriptomic profiling of peripheral blood cells in HPV‐associated carcinoma patients receiving combined valproic acid and avelumab

N Bozorgmehr, H Syed, S Mashhouri… - Molecular …, 2024 - Wiley Online Library
Human papillomavirus (HPV)‐associated cancer continues to evade the immune system by
promoting a suppressive tumor microenvironment. Therefore, immunotherapy appears to be …
被引用次数：3 相关文章

Transcriptomic profiling of peripheral blood cells in HPV-associated carcinoma patients receiving combined valproic acid and avelumab

N Bozorgmehr, H Syed, S Mashhouri… - Molecular …, 2024 - pubmed.ncbi.nlm.nih.gov
Human papillomavirus (HPV)-associated cancer continues to evade the immune system by
promoting a suppressive tumor microenvironment. Therefore, immunotherapy appears to be …

Transcriptomic profiling of peripheral blood cells in HPV-associated carcinoma patients receiving combined valproic acid and avelumab.

N Bozorgmehr, H Syed, S Mashhouri, J Walker… - Molecular …, 2023 - europepmc.org
Human papillomavirus (HPV)‐associated cancer continues to evade the immune system by
promoting a suppressive tumor microenvironment. Therefore, immunotherapy appears to be …
[HTML] nih.gov

[HTML][HTML] Transcriptomic profiling of peripheral blood cells in HPV‐associated carcinoma patients receiving combined valproic acid and avelumab

N Bozorgmehr, H Syed, S Mashhouri, J Walker… - Molecular …, 2024 - ncbi.nlm.nih.gov
Human papillomavirus (HPV)‐associated cancer continues to evade the immune system by
promoting a suppressive tumor microenvironment. Therefore, immunotherapy appears to be …

Transcriptomic profiling of peripheral blood cells in HPV-associated carcinoma patients receiving combined valproic acid and avelumab.

N Bozorgmehr, H Syed, S Mashhouri, J Walker… - Molecular …, 2023 - europepmc.org
Human papillomavirus (HPV)-associated cancer continues to evade the immune system by
promoting a suppressive tumor-microenvironment. Therefore, immunotherapy appears to be …